Mahmood I, Li Z
Immunotherapy. 2024; 16(13):879-894.
PMID: 39323402
PMC: 11457669.
DOI: 10.1080/1750743X.2024.2382081.
Ito Y, Yamamoto Y, Suzuki Y, Noda K, Nakajima A
Intern Med. 2021; 61(2):143-149.
PMID: 34334572
PMC: 8851185.
DOI: 10.2169/internalmedicine.7924-21.
Akiyama C, Shirai T, Sato H, Fujii H, Ishii T, Harigae H
Rheumatol Int. 2021; 42(7):1271-1280.
PMID: 33837447
DOI: 10.1007/s00296-021-04851-1.
Mahmood I, Tegenge M, Golding B
Antibodies (Basel). 2020; 9(2).
PMID: 32575458
PMC: 7345246.
DOI: 10.3390/antib9020024.
Mayu S, Isojima S, Miura Y, Nishimi S, Hatano M, Tokunaga T
Case Rep Rheumatol. 2019; 2019:4914631.
PMID: 30984438
PMC: 6432726.
DOI: 10.1155/2019/4914631.
Severe Recurrent Necrotizing Myopathy in Pregnancy: A Case Report.
Li Y, Meng L, Yuan Y, Meng L, Lin J, Bu B
Front Neurol. 2018; 9:1028.
PMID: 30546344
PMC: 6279913.
DOI: 10.3389/fneur.2018.01028.
Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.
Goyal N, Mozaffar T
Curr Treat Options Neurol. 2018; 20(9):37.
PMID: 30033499
DOI: 10.1007/s11940-018-0521-6.
A Case of New-Onset Dermatomyositis in the Second Trimester of Pregnancy: A Case Report and Review of the Literature.
Akalin T, Akkaya H, Buke B, Kocak I
Case Rep Obstet Gynecol. 2016; 2016:6430156.
PMID: 27478664
PMC: 4958446.
DOI: 10.1155/2016/6430156.
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.
Needham M, Mastaglia F
Neurotherapeutics. 2015; 13(1):132-46.
PMID: 26586486
PMC: 4720681.
DOI: 10.1007/s13311-015-0394-2.
Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
Wang D, Shu X, Tian X, Chen F, Zu N, Ma L
Clin Rheumatol. 2012; 31(5):801-6.
PMID: 22274797
DOI: 10.1007/s10067-012-1940-5.
A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.
Ensom M, Stephenson M
Hum Reprod. 2011; 26(9):2283-8.
PMID: 21771770
PMC: 3157629.
DOI: 10.1093/humrep/der227.
Therapeutic approaches in myositis.
Aggarwal R, Oddis C
Curr Rheumatol Rep. 2011; 13(3):182-91.
PMID: 21365210
DOI: 10.1007/s11926-011-0172-z.
Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis.
Linardaki G, Cherouvim E, Goni G, Boki K
Rheumatol Int. 2009; 31(1):113-5.
PMID: 19844719
DOI: 10.1007/s00296-009-1166-2.
Intravenous immunoglobulin therapy in neurological diseases during pregnancy.
Ringel I, Zettl U
J Neurol. 2006; 253 Suppl 5:V70-4.
PMID: 16998758
DOI: 10.1007/s00415-006-5012-0.
Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C
Clin Rheumatol. 2006; 26(7):1198-200.
PMID: 16779504
DOI: 10.1007/s10067-006-0337-8.
Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative.
Lampropoulos C, Hughes G, D Cruz D
Clin Rheumatol. 2006; 26(6):981-3.
PMID: 16670831
DOI: 10.1007/s10067-006-0222-5.
[Rare autoimmune rheumatic illnesses during pregnancy. Systemic sclerosis, polymyositis/dermatomyositis and vasculitis].
Doria A, Iaccarino L, Ghirardello A, Arienti S, Zampieri S, Rampudda M
Z Rheumatol. 2006; 65(3):200, 202-6, 208.
PMID: 16670810
DOI: 10.1007/s00393-006-0059-y.
